In focus · trending topic

Gynecological Cancer

1 stories · following the connections

TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer

By Nasdaq OMXNov 20, 2017, 12:01 PM UTC